Why the study?
The study evaluated the effect of tirzepatide in patients with type 2 diabetes undergoing hemodialysis monitored with real-time continuous glucose monitoring.
Does tirzepatide improve glycemic control without worsening nutritional status in patients with type 2 diabetes undergoing hemodialysis?
Does tirzepatide improve glycemic control without worsening nutritional status in patients with type 2 diabetes undergoing hemodialysis?
Tirzepatide safely improved glycemic control and reduced insulin requirements without compromising nutritional status in two hemodialysis patients with type 2 diabetes.
Answers are grounded in this paper and cite their sources.
Tirzepatide may improve glycemic metrics in T2D on HD without nutritional harm; hypothesis-generating case series leaves open need for larger trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Akiko Mizuno (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: